A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma
Clinical trial NCT05015621 · UNKNOWN
Trial details
- NCT number
- NCT05015621
- Sponsor
- Hutchison Medipharma Limited
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-18
- Primary completion
- 2025-05-31
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.